[HTML][HTML] Myocarditis, pulmonary hemorrhage, and extensive myositis with rhabdomyolysis 12 days after first dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 …
S Al-Rasbi, JS Al-Mqbali, R Al-Farsi… - The American journal …, 2022 - ncbi.nlm.nih.gov
Objective: Unusual clinical course Background: The COVID-19 pandemic is a current global
crisis, and there are hundreds of millions of individuals being vaccinated worldwide. At …
crisis, and there are hundreds of millions of individuals being vaccinated worldwide. At …
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine …
S Al-Rasbi, JS Al-Maqbali, R Al-Farsi… - American Journal of …, 2022 - squ.elsevierpure.com
Objective: Background: Case Report: Conclusions: Unusual clinical course The COVID-19
pandemic is a current global crisis, and there are hundreds of millions of individuals being …
pandemic is a current global crisis, and there are hundreds of millions of individuals being …
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine …
S Al-Rasbi, J Salim Al-Mqbali… - American Journal of …, 2022 - search.ebscohost.com
Abstract Patient: Male, 37-year-old Final Diagnosis: Immune-mediated myocarditis•
pulmonary vasculitis• myositis• thrombocytopenia Symptoms: Episode of hemoptysis with …
pulmonary vasculitis• myositis• thrombocytopenia Symptoms: Episode of hemoptysis with …
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine …
S Al-Rasbi, JS Al-Maqbali, R Al-Farsi… - American Journal of …, 2022 - squ.pure.elsevier.com
BACKGROUND The COVID-19 pandemic is a current global crisis, and there are hundreds
of millions of individuals being vaccinated worldwide. At present, there have been few …
of millions of individuals being vaccinated worldwide. At present, there have been few …
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine …
S Al-Rasbi, JS Al-Maqbali, R Al-Farsi… - The American Journal …, 2022 - europepmc.org
BACKGROUND The COVID-19 pandemic is a current global crisis, and there are hundreds
of millions of individuals being vaccinated worldwide. At present, there have been few …
of millions of individuals being vaccinated worldwide. At present, there have been few …
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine …
S Al-Rasbi, JS Al-Maqbali, R Al-Farsi… - … journal of case …, 2022 - pubmed.ncbi.nlm.nih.gov
BACKGROUND The COVID-19 pandemic is a current global crisis, and there are hundreds
of millions of individuals being vaccinated worldwide. At present, there have been few …
of millions of individuals being vaccinated worldwide. At present, there have been few …
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine …
S Al-Rasbi, JS Al-Maqbali, R Al-Farsi… - American Journal of …, 2022 - squ.elsevierpure.com
Objective: Background: Case Report: Conclusions: Unusual clinical course The COVID-19
pandemic is a current global crisis, and there are hundreds of millions of individuals being …
pandemic is a current global crisis, and there are hundreds of millions of individuals being …
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine …
S Al-Rasbi, JS Al-Maqbali, R Al-Farsi… - The American Journal …, 2022 - europepmc.org
BACKGROUND The COVID-19 pandemic is a current global crisis, and there are hundreds
of millions of individuals being vaccinated worldwide. At present, there have been few …
of millions of individuals being vaccinated worldwide. At present, there have been few …